Kura Oncology
The Associate Director/Director of Statistical Programming provides technical leadership and programming support for Clinical Development, coordinating with biostatisticians, clinical data managers, CROs, and other stakeholders. The role supports the creation, implementation, and maintenance of statistical programming deliverables from study start-up through regulatory submission and post-marketing support. This position also drives process improvements, CDISC implementation, and quality systems while mentoring junior staff and contributing to resourcing and recruitment.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2014
Kura Oncology is a precision oncology biotechnology company focused on realizing the promise of targeted medicines to help patients with cancer lead better, longer lives. The company discovers and develops small-molecule therapies designed to inhibit specific cancer-driving pathways and genetic alterations, advancing programs through preclinical and clinical development. Kura works with clinical investigators and partners to test its candidates in genetically defined patient populations with the goal of delivering meaningful, durable treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kura Oncology.
Kura Oncology Inc. Q4 Loss Increases
1 week ago
Associate Director, Statistical Programming
Definium Therapeutics
Associate Director, Statistical Programming
Corcept Therapeutics
Senior Manager, Statistical Programming
lifelancer
Associate Director, Statistical Programming
Centessa Pharmaceuticals
Assoc Director, Statistical Programming
Diversity Employment
Manager/Sr Manager of Statistical Programming
Oruka Therapeutics